Neuroprotective effects of D3 dopamine receptor agonists
- 1 July 2001
- journal article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 7 (3) , 213-223
- https://doi.org/10.1016/s1353-8020(00)00061-4
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- A Comparative Review of New AntipsychoticsThe Canadian Journal of Psychiatry, 1999
- Pramipexole — a new dopamine agonist for the treatment of Parkinson's diseaseJournal of the Neurological Sciences, 1999
- Structure/function in neuroprotection and apoptosisAnnals of Neurology, 1998
- Excitotoxicity and nitric oxide in parkinson's disease pathogenesisAnnals of Neurology, 1998
- Monoamine Oxidase Molecular Activity in Platelets of Parkinsonian and Demented PatientsNeurodegeneration, 1996
- First Trimester Development of the Human Nigrostriatal Dopamine SystemExperimental Neurology, 1996
- Ceramide Induces Apoptosis in Cultured Mesencephalic NeuronsJournal of Neurochemistry, 1996
- Neural apoptosisAnnals of Neurology, 1995
- Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's diseaseNeuroscience Letters, 1994
- Parkinson's disease: pathophysiologyThe Lancet, 1991